This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Wysham: I'd like ...

Share on Pinterest Emerging evidence suggests that oral semaglutide may reduce the risk of heart failure–related events in people with type 2 diabetes. JasonDoiy/Getty Images Oral semaglutide may ...

An analysis shows that oral semaglutide significantly lowers the risk of heart failure (HF) outcomes in patients with type 2 diabetes and a history of HF. Heart failure (HF) is a major complication ...

Type 2 diabetes doesn’t just raise the risk of heart disease—it physically reshapes the heart itself. Researchers studying donated human hearts found that diabetes disrupts how heart cells produce ...

Learn how GLP-1 drugs may protect the heart by lowering inflammation, improving blood vessels, and reducing key risk factors.

Higher variability in the levels of total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, or triglycerides was independently associated with an ...

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? You already know that living with type 2 diabetes means having blood sugar ...

The intake of oral semaglutides such as Wegovy or Rybelsus among adults with type 2 diabetes (T2D) was associated with a reduced risk of heart failure (HF) compared to those who took a placebo, ...

Knowing your blood type is important information that can come in handy during a medical emergency. It can also tell you more about which medical conditions you're more at risk for, such as heart ...

Can weight loss reverse heart failure? A new study shows that heart muscle cells regain strength and muscle contractions ...